5 reports

  • SEATTLE GENETICS, INC.
  • 7.1.5 TABLE FOR LICENSING DEALS WITH DISCLOSED DEAL VALUE

Kite Pharma Announces Positive Topline KTE-C## Data from ZUMA-## Business Wire.

  • Cancer Immunotherapy
  • Lung Cancer
  • Pharmaceutical
  • Therapy
  • Innate Pharma
  • INNATE PHARMA
  • ID No. Name

Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-beta, CXCR4, CSF-1R, CD47-SIRPalpha, adenosine pathway & STING 2018 This Competitive Intelligence report analyzes the competitive field of modulators of the tumor microenvironment via IDO & TDO, TGF-beta/R, CXCR4, novel chemokines, CSF-1R, CD47-SIRPalpha,...

  • Pharmaceutical
  • Therapy
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • Innate Pharma
  • Innate Pharma SA, Pharmaceuticals & Healthcare, Deal Details
  • Innate Pharma SA, Subsidiaries

Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products.The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies...

  • Healthcare
  • Hospital
  • Pharmaceutical
  • United States
  • Innate Pharma
  • COMPANY- INNATE PHARMA S.A.
  • COMPANY- INNATE PHARMA

“IMMUNE CHECKPOINT THERAPEUTICS – HOT TARGETS & PIPELINE ANALYSIS” gives comprehensive insights on the various Immune Checkpoint modulators being developed for the treatment of various diseases. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines...

  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Agenus Inc.
  • Innate Pharma
  • INNATE PHARMA: IMMUNE CHECKPOINT INHIBITORS PARTNERSHIPS
  • INNATE PHARMA: IMMUNE CHECKPOINT INHIBITORS PIPELINE, 2015

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although oncology continues to be one of the most active areas in terms of drug development, there is still a significant unmet need. The focus of drug...

  • Cancer Immunotherapy
  • Pharmaceutical
  • Therapy
  • Market Size
  • Innate Pharma